The IPO is entirely a fresh equity issue of Rs 2,800 crore. This is the first IPO from a JSW Group company in 13 years after JSW Energy listed in 2010.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale